|
Market Closed -
Euronext Paris
09:25:00 12/08/2026 pm IST
|
After hours 10:47:27 pm | |||
| 333.50 EUR | -1.91% |
|
334.00 | +0.15% |
| 29/07 | Virbac, without the alibi |  |
| 21/07 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRBAC | Veterinary Drugs | -1.91% | -1.48% | -6.71% | +1.68% | +0.45% | 328.69Cr |  |  | |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
